COMPASS PATHWAYS PLC - AMERICAN DEPOSITORY SHARES
4,5950
25-ноября-24 11:16:50
15 мин. задержка
Акции
+0,1850
+4,20%
Сегодняшний диапазон
4,3700 - 4,6400
ISIN
N/A
Источник
NASDAQ
- Котировки
- Графики
Новости
- Статистика
-
COMPASS Pathways launches phase II clinical trial of psilocybin therapy in anorexia nervosa
28 июл 2022 04:00:00 Источник Nasdaq GlobeNewswire
-
COMPASS Pathways plc to announce second quarter 2022 financial results on 4 August 2022
26 июл 2022 08:00:00 Источник Nasdaq GlobeNewswire
-
COMPASS Pathways appoints Kabir Nath as Chief Executive Officer
19 июл 2022 08:00:00 Источник Nasdaq GlobeNewswire
-
23 май 2022 07:00:00 Источник Nasdaq GlobeNewswire
-
12 май 2022 08:00:00 Источник Nasdaq GlobeNewswire
-
COMPASS Pathways plc announces first quarter 2022 financial results and business highlights
10 май 2022 07:00:00 Источник Nasdaq GlobeNewswire
-
COMPASS Pathways to fund study of COMP360 psilocybin in autistic adults
09 май 2022 07:00:00 Источник Nasdaq GlobeNewswire
-
COMPASS Pathways plc to announce first quarter 2022 financial results on 10 May 2022
03 май 2022 08:00:00 Источник Nasdaq GlobeNewswire
-
03 май 2022 07:00:00 Источник Nasdaq GlobeNewswire
-
20 апр 2022 07:00:00 Источник Nasdaq GlobeNewswire
-
COMPASS Pathways to participate in Needham Healthcare conference
04 апр 2022 08:00:00 Источник Nasdaq GlobeNewswire
-
COMPASS Pathways and partners launch The Centre for Mental Health Research and Innovation, in the UK
24 мар 2022 05:00:00 Источник Nasdaq GlobeNewswire
-
COMPASS Pathways to participate in Cowen and Roth investor conferences
02 мар 2022 07:00:00 Источник Nasdaq GlobeNewswire
-
24 фев 2022 07:12:48 Источник Nasdaq GlobeNewswire
-
17 фев 2022 12:20:59 Источник Nasdaq GlobeNewswire
-
19 янв 2022 07:00:00 Источник Nasdaq GlobeNewswire
-
COMPASS Pathways to participate in H.C. Wainwright investor conference
10 янв 2022 07:00:00 Источник Nasdaq GlobeNewswire
-
COMP360 psilocybin study of 89 healthy participants published in Journal of Psychopharmacology
04 янв 2022 07:00:00 Источник Nasdaq GlobeNewswire
-
COMPASS Selected for Addition to NASDAQ Biotechnology Index
17 дек 2021 07:00:00 Источник Nasdaq GlobeNewswire
-
COMPASS Pathways announces changes in Executive Team
16 дек 2021 07:40:00 Источник Nasdaq GlobeNewswire